Healthcare / Health Information ServicesNasdaqCM
$5.38
+0.19 (+3.66%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $4.4M · quality 49.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
51/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$101M
P/E
14.9x
↓EV/EBITDA
6.3x
↓ROE
4.0%
↑Gross Margin
67.3%
↑Debt/Equity
0.20
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2010–2025 · 15 años de histórico normalizado
Revenue CAGR
+63.1%
FCF CAGR
—
FCF margin
17.1%
FCF / Net income
3.65x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $109.4M · net income $5.1M · FCF $18.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||
| Revenue | $109.4M | $109.4M | $92.1M | $71.5M | $62.5M | $4.5M | $43.3M | $24.6M | $21.2M | $8.4M | $6.2M | $7.2M | $6.5M | $4.7M | $2.0M | $1.1M | $71065.00 |
| Net Income | $5.1M | $5.1M | $-20.1M | $-17.6M | $-11.4M | $378079.00 | $-2.2M | $-3.1M | $226344.00 | $-2.1M | $-1.5M | $-595140.00 | $-1.0M | $-267290.00 | $-454553.00 | $-2.1M | $-2.0M |
| EBITDA | $16.6M | $16.6M | $-8.9M | $-21.3M | $-9.4M | $2.3M | $-59431.00 | $-2.4M | $496634.00 | $-1.8M | $-1.3M | $-263457.00 | $-761988.00 | $-73745.00 | $-267818.00 | $13.6M | $-1.8M |
| EPS | 0.27 | 0.27 | -1.10 | -1.03 | -0.64 | 0.02 | -0.15 | -0.23 | 0.02 | -0.21 | -0.15 | -0.06 | -0.12 | — | — | — | — |
| Gross Margin | 67.3% | 67.3% | 64.5% | 60.0% | 62.4% | 789.0% | 55.7% | 62.8% | 57.6% | 70.6% | 69.9% | 49.8% | 50.5% | 60.2% | 91.5% | — | — |
| Operating Margin | 11.0% | 11.0% | -6.7% | -24.5% | -19.7% | 8.0% | -4.9% | -15.0% | 0.8% | -25.3% | -25.5% | -8.3% | -15.8% | -5.7% | -22.2% | 1212.7% | -2597.9% |
| Net Margin | 4.7% | 4.7% | -21.8% | -24.6% | -18.3% | 8.4% | -5.1% | -12.8% | 1.1% | -25.0% | -24.8% | -8.2% | -15.8% | -5.7% | -22.2% | -190.8% | -2827.0% |
| Balance Sheet | |||||||||||||||||
| Debt/Equity | 0.20 | 0.20 | 0.28 | 0.29 | 0.00 | — | — | — | — | — | — | — | — | — | — | 0.00 | 0.53 |
| Current Ratio | 5.37 | 5.37 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||
| Free Cash Flow | $18.7M | $18.7M | $4.4M | $-8.1M | $10.4M | $625717.00 | $-6.4M | $-1.7M | $758193.00 | $-1.5M | $-644399.00 | $513064.00 | $-63334.00 | $1.1M | $-626263.00 | $-534609.00 | $-1.3M |
| Returns | |||||||||||||||||
| ROE | 4.0% | 4.0% | -17.2% | -13.9% | -9.1% | 0.3% | -4.4% | -7.0% | 1.2% | -33.8% | -19.7% | -6.7% | -22.2% | -16.0% | -32.4% | -133.5% | -106.1% |
| Valuation | |||||||||||||||||
| P/E | 14.94 | 14.94 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 6.33 | 6.33 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 0.80 | 0.80 | 0.86 | 1.79 | 2.53 | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | |||||||||||||||||
| Revenue Growth | 18.8% | 18.8% | 28.8% | 14.5% | — | -89.6% | 76.1% | 16.0% | 151.5% | 35.8% | -14.0% | 11.0% | 39.0% | 128.4% | 84.3% | 1464.1% | — |
| EPS Growth | 124.5% | 124.5% | -6.8% | -60.9% | — | 113.3% | 34.8% | -1250.0% | 109.5% | -40.0% | -150.0% | 50.0% | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
20.9%
EPS terminal req.
$0.48
Spread vs growth
103.6%
5Y implied EPS CAGR
16.4%
EPS terminal req.
$0.58
Spread vs growth
108.1%
10Y implied EPS CAGR
13.2%
EPS terminal req.
$0.93
Spread vs growth
111.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-55.7%
Start / end P/E
n/dx → n/dx
EPS bridge
-1.10 → 0.27
Residual
-55.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.